Yatin Suneja
Analyst
Guggenheim
Equibles does not estimate personal net worth.
About Yatin Suneja
Yatin Suneja is recorded as Analyst at Guggenheim. Yatin Suneja has spoken on 4 earnings calls and 1 other investor event across 5 companies, most recently for Sionna Therapeutics, Inc. on September 14, 2026. Those appearances were for Sionna Therapeutics, Inc. (SION), Praxis Precision Medicines, Inc. (PRAX), DBV Technologies S.A. (DBVT), Phathom Pharmaceuticals, Inc. (PHAT) and Anaptysbio, Inc (ANAB). The companies whose calls Yatin Suneja spoke on are classified in the Healthcare sector.
Yatin Suneja on recent calls
“Maybe just I have a question and how should we think about the essay that you have used? Any sort of thought on the essay and sort of the predictability of that?”
“I have two questions with regard to the Power 3 study. Can you just articulate to us how will that study help you move towards the front line setting or to an FOS?”
“So the data look pretty much in line to what you have generated in a toddler if you look at the younger patients. So the question is, have you looked at the breakdown between four to five versus six to seven years old in this study?”
“You know, as you are sort of trying to go more deeper into the GI community, can you just talk about the type of patients you are seeing right now? Can you also talk about, you know, the penetration you might be seeing in nerd versus GERD population?”
“Yelan, thank you so much for the details. I appreciate that. And I actually like the split, as you know, from the analysis on the royalties. So it's pretty good.”
Affiliation history
-
Guggenheim
Analyst
Source not stated
Current
Company network
Anaptysbio, Inc
ANAB
Biotechnology · Healthcare
1 appearance
Latest appearance 2025-09-29
View calls and events